CONSHOHOCKEN, PA — Cencora Inc. (NYSE: COR) will report fourth-quarter and fiscal 2026 financial results November 4, giving investors an update on the performance of one of the world’s largest pharmaceutical distributors, which generates more than $300 billion in annual revenue.
The Conshohocken-based company will release its results before the New York Stock Exchange opens, followed by an earnings conference call at 8:30 a.m. Eastern Time.
President and Chief Executive Officer Robert P. Mauch and Executive Vice President and Chief Financial Officer Eva C. Boratto will participate in the call to discuss the results.
Cencora operates a global pharmaceutical distribution and services business, supplying medications and healthcare products to providers while working with pharmaceutical manufacturers on market access and related services.
The company ranks 10th on the Fortune 500 and 16th on the Fortune Global 500, reflecting its position in the pharmaceutical supply chain.
Investors can access the live earnings webcast at investor.cencora.com. A replay is expected to become available approximately one hour after the call concludes and will remain accessible for one year.
The company advises investors to check its investor relations website for updates to the webcast schedule and replay availability.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.